The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000731392
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
7/05/2026
Date registered
Help: Date registered
17/06/2026
Date last updated
Help: Date last updated
17/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
17/06/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Implementation and scale-up of a co-designed physical activity promotion program for people with moderate-to-profound disabilities
Scientific title
Implementation and scale-up of a co-designed physical activity promotion program for people with moderate-to-profound disabilities
Additional trial identifiers [1] 317217 0
MRF2023767
Universal Trial Number (UTN)
Trial acronym
APAP-OMNI
Related trial records

Health condition
Health condition(s) studied:
Physical inactivity 341819 0
Physical Disability 342204 0
Intellectual disability 342205 0
Condition category
Condition code
Musculoskeletal 337890 337890 0 0
Other muscular and skeletal disorders
Neurological 337891 337891 0 0
Other neurological disorders
Physical Medicine / Rehabilitation 337892 337892 0 0
Physiotherapy
Physical Medicine / Rehabilitation 337893 337893 0 0
Occupational therapy
Physical Medicine / Rehabilitation 338327 338327 0 0
Other physical medicine / rehabilitation

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Brief name: The APAP-OMNI Program

APAP-OMNI is a client-centred, community-based program designed to empower people with moderate-to-profound disability and high support needs to adopt and maintain a physically active lifestyle. APAP-OMNI is delivered in the community by trained Allied Health Professionals (i.e., exercise physiology, physiotherapy, occupational therapy) in collaboration with the client and their relevant social support (e.g., family, support worker, community service providers). Briefly, APAP-OMNI comprises four steps:
Step 1: Information Gathering and Sharing (1-2 sessions). This includes participants demographic information, medical history, communication preferences, and access to physical activity resources will be collected to design a tailored physical activity program that is safe, sustainable, enjoyable and effective. The activities included in this step aim to reduce the time commitment required to collect this information while prioritising activities that build rapport and support the client’s voice and autonomy. This information will be collected via medical records, referral documentation, one on one interviews with the client / family / support worker and the Support Needs Assessment Tool – Sport and Exercise (SNAT-SE) to assess required supports for participating in sport and exercise related activities.
Step 2: Identifying motivators, barriers, facilitators and opportunities for participating in physical activity (2-3 sessions). During Step 2, Allied Health Professionals (AHPs) will conduct one-to-one client-centred consultations with participants (and parents/caregivers where appropriate) to identify motivators, barriers, facilitators and opportunities for increased physical activity participation. Information will be gathered through guided interviews, discussion-based activities, review of daily routines and available resources, and consideration of relevant functional abilities, environmental factors, and assistive equipment where applicable. Allied health professionals will then apply tailored behaviour change strategies to identify: 1) motivators, barriers and facilitators for increased physical activity participation (Step 2A); and 2) opportunities for physical activity that align with the client's interests, available time and resources (Step 2B).
Step 3: Facilitating safe, sustainable, enjoyable and effective physical activity (2-3 sessions). The object of Step 3 of the APAP-OMNI is to facilitate participation in the client’s chosen physical activity. Firstly in this step, AHPs work collaboratively with clients through individual consultations to develop and implement an Action Plan (Step 3A). Information collected during Steps 1 and 2 is used to identify participation goals, required supports, potential barriers, and strategies to facilitate successful participation. Where relevant, clinicians may also consult with family members, support workers, community activity providers, schools, employers, or other stakeholders involved in supporting participation. The action plan is a personalised document that outlines the client's chosen physcial activity, participation goals, specific actions required to support participation, the person responsible for each action, and timelines for completion. Examples of actions that may be included in the Action Plan include identifying suitable community exercise or sport program, arrangin transport, adapting equiptment, modifyin home or community environments, educating activity providers regarding disability-specific needs, organising support worker assistance, establishing social supports, setting reminders, monitoring activity participation, and identifying rewards for achieveing participation goals. For some clients, the Action Plan may also include a graduated participation schedule or simple exercise program designed to biuld the skills, confidence, fitness or endurance required to participate successfully in their chosen activity.
Then, the AHP focuses on implementing the Action Plan and supporting participation in the community (Step 3B). Support may be provided through face-to-face consultations, telephone calls, telehealth appointments, email communication, text messages, environmental modifications, equipment recommendations, liaison with community providers, and ongoing review of progress towards participation goals. The intensity and type of support provided are tailored to the client's goals, abilities, and participation context.

Step 4: Promoting ongoing participation in physical activity (1-2 sessions).
The object of Step 4 is to promote the long-term maintenance of physical activity participation after completion of the APAP-OMNI program. During this step, AHPs work collaboratively with clients, and where appropriate their families, caregivers, support workers and community providers, to develop a personalised Participation Promotion Plan that supports sustainable engagement in physical activity.
The Participation Promotion Plan is a written document that summarises the physical activity goals, successful participation strategies identified during the program, key sources of social and community support, and plans for maintating partcipation over time. The plan may include short-, medium-, and long-term participation goals (e.g., 3-6 month , and 12-month goals), strategies for managing anticipated barriers such as illness, injury, weather changes, transport difficulties, changes in support arrangements or funding, and contingency plans for restarting participation following interruptions. The plan may also identify opportunities for progression of physical activity participation, including increasing attendance frequency, participation duration, skill development, transition to new activities, or progression from supported to independent participation where appropriate. Examples of components that may be included in the Participation Promotion Plan include shedules for ongoing participation, identification of community programs and support networks, strategies for self-monitoring and self-evaluation, future goal setting activities and guidance regarding safe progression of physical activity. A physical or electronic copy of the plan is provided to the client to support ongoing participation after completion of the intervention.

The intervention is delivered over 16 weeks and comprises up to 10 sessions, each lasting between 30 and 60 minutes depending on the participants needs and session objectives. Sessions are typically delivered more frequently during the inital phase of the program, with reduced frequency in the later strages as participants transition towards greater independence and sustained participation.

The study will be conducted across eight community-based allied health clinics in Queensland, Australia, serving communities in both metropolitan and regional areas (Brisbane, Gold Coast, Sunshine Coast, Townsville and Cairns). The clinics are multidisciplinary, providing services such as physiotherapy, exercise physiology and occupational therapy.

AHPs will receive training in the delivery of APAP-OMNI during the month prior to crossing over to the intervention period. The workforce training package comprises of a hybrid of online and face-to-face training modules. The online component involves six self-paced modules that provide AHPs with a comprehensive foundation for delivering the APAP-OMNI program, covering its aims, implementations strategies and trial-specific responsibilities. The online modules are estimated to take approximately 3.5 hours to complete. Following completion of the self-paced online modules, AHPs will participate in a face-to face workshop focused on the practical application of APAP-OMNI program. The workshop will use an interactive, case-based format organised around the four-step APAP-OMNI delivery process. Training activities will include guided practice in infomatin gathering and sharing, behavioural change techniques, motivational interviewing, goal setting, action planning, communtiy participation planning and problem-solving strategies to support physical activity participation among individuals with moderate to profound disability. The workshop will incorporate reflective learning activities, case-based discussions, role-play senarios and collaborative community service planning exercises designed to build AHP confidence and capability in delivering sustainable, community-based physical activity support.

For quality assurance and to support intervention fidelity, AHPs will complete an Essential Elements Checklist (EEC) following each of the 10 APAP-OMNI intervention sessions. The EEC records session details (date, duration, and AHP name), the APAP-OMNI step(s) completed during the session and a structured summary of session content and participant engagement. AHPs will document the key focus of the session, behaviour change strategies or tools used, participant or caregiver responses, agreed actions and plans, responses to participation, and any barriers, safety considerations or contextual factors affecting implementation or progress.
Intervention code [1] 333984 0
Rehabilitation
Intervention code [2] 333985 0
Lifestyle
Intervention code [3] 333986 0
Behaviour
Description of the comparator or control
Usual care. During each clinic’s 16-week control period, participants will continue to receive their usual care. Usual care may include existing therapy or health services such as physiotherapy, occupational therapy, speech and language therapy, and/or medical practitioner visits. Usual care is expected to vary between participants, and most participants are not anticipated to receive direct physical activity promotion support during the control period.
Control group
Active

Outcomes
Primary outcome [1] 345335 0
Canadian Occupational Performance Measure (COPM) - Performance Score.
Timepoint [1] 345335 0
Assessed at T1: During the 16-week usual care control period; T2: start of the 16-week intervention period, prior to receiving APAP-OMNI; and T3: end of the 16-week intervention period, approximately 16 weeks after commencement of APAP-OMNI.
Primary outcome [2] 345337 0
Canadian Occupational Performance Measure (COPM) - Satisfaction Score
Timepoint [2] 345337 0
Assessed at T1: during the 16-week usual care control period; T2: start of the 16-week intervention period, prior to receiving APAP-OMNI; and T3: end of the 16-week intervention period, approximately 16 weeks after commencement of APAP-OMNI.
Primary outcome [3] 345719 0
Physical Activity
Timepoint [3] 345719 0
Assessed at T1: during the 16-week usual care control period; T2: start of the 16-week intervention period, prior to receiving APAP-OMNI; and T3: end of the 16-week intervention period, approximately 16 weeks after commencement of APAP-OMNI.
Secondary outcome [1] 461319 0
Functional impairment
Timepoint [1] 461319 0
Assessed at T1: start of the 16-week usual care control period; T2: start of the 16-week intervention period, prior to receiving APAP-OMNI; and T3: end of the 16-week intervention period, approximately 16 weeks after commencement of APAP-OMNI.
Secondary outcome [2] 461320 0
Quality of Life
Timepoint [2] 461320 0
Assessed at T1: start of the 16-week usual care control period; T2: start of the 16-week intervention period, prior to receiving APAP-OMNI; and T3: end of the 16-week intervention period, approximately 16 weeks after commencement of APAP-OMNI.
Secondary outcome [3] 461322 0
Willingness to allocate funds to APAP-OMNI program
Timepoint [3] 461322 0
T3 - end of the 16-week intervention period, approximately 16 weeks after commencement of APAP-OMNI.

Eligibility
Key inclusion criteria
Eligibility criteria: (1) Age greater than or equal to 10 years; (2) Have a moderate-to-profound physical or intellectual disability defined as using wheeled mobility or require personal support for fundamental tasks of daily living (dressing, eating, toileting, communication, or community mobility); (3) Living in the community within a 50-kilometre radius of a partner organisation clinic; (4) Insufficiently physically active; (5) Deemed safe to participate in a physical activity program [via pre-exercise screening tool]
Minimum age
10 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Exclusion criteria: (1) History of violence and/or current uncontrolled substance abuse.

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Participating clinics will be randomly allocated to one of three sequences determining the timing of crossover from control to intervention. Given the small number of clusters, allocation will be undertaken using a simple random allocation procedure by a member of the research team who is not involved in intervention delivery.
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other
Other design features
This study uses a balanced staircase varient of a stepped-wedge cluster design. Eight clincs are allocated to one of three crossover sequences. At each 16-week step, one group of clinics crosses from the contol condition (usual care) to the APAP-OMNI intervention condition. Crossover occurs at Weeks 16, 32, and 48, resulting in three crossover steps.
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
The sample size was determined using methods for stepped wedge cluster trial design. This approach takes into consideration the within-period intracluster correlation (ICC = 0.03), the between-period intracluster correlation (0.015), and the correlation between responses from the same individual across time periods (r=0.25). These parameters were based on previous studies involving similar interventions delivered by allied health professional and from our own previous work. Projected differences between the intervention and control conditions were based on prior findings: (i) Goal attainment: 2 points on the goal attainment scale; and (ii) Daily moderate to vigorous physical activity (MVPA): 13 mins difference per day.
For both primary outcomes, estimates of the standard deviation (Goal Attainment = 2.5 pts, MVPA = 20 mins/day) were based on our previous work and conservatively inflated by 50% in anticipation of higher observed variance in the diverse study population.
To control for multiplicity associated with the multiple primary outcomes and three time points, alpha was conservatively set at 0.01.
Based on these assumptions and with 8 participating clinics, a sample size of 48 participants (6 per clinic) will provide > 95% power to detect the projected difference in goal attainment and 84% power to detect the projected difference in daily MVPA. To accommodate an anticipated attrition rate of up to 20%, between 7 and 8 participants per clinic will be enrolled, providing an overall sample size of at least 60 participants.
Primary and secondary outcomes will be analysed using generalised linear mixed models to account for the clustered and repeated-measures nature of the data in this stepped-wedge trial design. Models will include fixed effects for treatment condition (usual care vs APAP-OMNI) and time, with random effects for clinic, clinic-by-time interaction, and repeated measures within participants. Appropriate distributions and link functions will be selected based on the nature of the outcome variable. Analyses will follow the intention-to-treat principle, with all available data included. Sensitivity analyses may be undertaken to assess the impact of missing data.

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 321794 0
Government body
Name [1] 321794 0
Australian Government Department of Health, Disability and Ageing, Medical Research Future Fund (MRFF)
Country [1] 321794 0
Australia
Primary sponsor type
University
Name
The University of Queensland
Address
Country
Australia
Secondary sponsor category [1] 324642 0
None
Name [1] 324642 0
Address [1] 324642 0
Country [1] 324642 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320339 0
The University of Queensland Human Research Ethics Committee B
Ethics committee address [1] 320339 0
Ethics committee country [1] 320339 0
Australia
Date submitted for ethics approval [1] 320339 0
26/08/2025
Approval date [1] 320339 0
16/10/2025
Ethics approval number [1] 320339 0
2023/HE001977

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150142 0
Prof Stewart Trost
Address 150142 0
The University of Queensland, School of Human Movement and Nutrition Sciences, Faculty of Health, Medicine and Behavioural Sciences, St Lucia QLD, 4072
Country 150142 0
Australia
Phone 150142 0
+61 0401368975
Fax 150142 0
Email 150142 0
Contact person for public queries
Name 150143 0
Stewart Trost
Address 150143 0
The University of Queensland, School of Human Movement and Nutrition Sciences, Faculty of Health, Medicine and Behavioural Sciences, St Lucia QLD, 4072
Country 150143 0
Australia
Phone 150143 0
+61 0401368975
Fax 150143 0
Email 150143 0
Contact person for scientific queries
Name 150144 0
Stewart Trost
Address 150144 0
The University of Queensland, School of Human Movement and Nutrition Sciences, Faculty of Health, Medicine and Behavioural Sciences, St Lucia QLD, 4072
Country 150144 0
Australia
Phone 150144 0
+61 0401368975
Fax 150144 0
Email 150144 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• De-identified individual participant data:
• Primary outcome(s)
What types of analyses could be done with individual participant data?
• Systematic reviews and meta-analyses
• Studies exploring new research questions
• Teaching research methods or developing new statistical techniques
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
Not yet decided
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: Data may be obtained by contacting the Principal Investigator, Professor Stewart Trost, The University of Queensland, via email at [email protected].

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.